Genflow Biosciences plc reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was GBP 1.34 million. Basic loss per share from continuing operations was GBP 0.00457.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 GBX | 0.00% | 0.00% | +117.54% |
Jun. 12 | EARNINGS AND TRADING: Distil loss widens; Genflow welcomes grant | AN |
May. 30 | Genflow Biosciences receives 50% of grant for sarcopenia project | AN |
1st Jan change | Capi. | |
---|---|---|
+117.54% | 13.75M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- GENF Stock
- News Genflow Biosciences plc
- Genflow Biosciences plc Reports Earnings Results for the Full Year Ended December 31, 2022